Xie, Xiong-Wei <br/><br/>
Liquiritigenin attenuates cardiac injury induced by high fructose-feeding through fibrosis and inflammation suppression.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Feb 2017 
 - 694-704 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2016.12.066  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--metabolism<br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Collagen Type I--metabolism<br/>Collagen Type II--metabolism<br/>Fibrosis--drug therapy<br/>Flavanones--pharmacology<br/>Fructose--administration & dosage<br/>Heart--drug effects<br/>Heart Injuries--chemically induced<br/>Inflammation--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Myocardium--metabolism<br/>NF-kappa B--metabolism<br/>Signal Transduction--drug effects<br/>Transforming Growth Factor beta1--metabolism